Elevation Wealth Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.8K Buy
249
+149
+149% +$9.93K 0.01% 647
2026
Q1
$6.28K Buy
100
+20
+25% +$1.39K ﹤0.01% 640
2025
Q4
$5.31K Buy
80
+50
+167% +$3.23K ﹤0.01% 613
2025
Q3
$2.02K Buy
+30
New +$2.37K ﹤0.01% 647

Other funds holding DXCM

Elevation Wealth Partners's DXCM Position: Q2 2026 in Review

Elevation Wealth Partners increased its DexCom (DXCM) stake by 149% in Q2 2026, buying an estimated $9.93K and bringing the position to 249 shares worth $16.8K. The position accounts for 0.01% of the portfolio, ranked #647.

Elevation Wealth Partners first reported a position in DXCM in Q3 2025 and has held it in 4 quarters since. 314 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Elevation Wealth Partners held 249 shares of DexCom worth $16.8K as of Q2 2026.
  • Elevation Wealth Partners bought 149 DexCom shares in Q2 2026, an estimated $9.93K.
  • DexCom made up 0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #647 holding.
  • Elevation Wealth Partners first reported a position in DexCom in Q3 2025 and has held it in 4 quarters since.
  • 314 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.